Sam Altman’s rival to Neuralink reportedly eying gene therapy technology

1 hour ago 1
Spinning DNA strand and fluid particles.

Torsten Asmus/iStock via Getty Images

A novel gene therapy idea is reportedly among the focus areas considered by Merge Labs, a new brain-computer interface startup positioned by its backers, including Sam Altman and his AI firm OpenAI, as a potential rival to Tesla (TSLA

Recommended For You

More Trending News

Read Entire Article